Try our Advanced Search for more refined results
Intellectual Property
-
April 16, 2025
Sterlington Adds Ex-Loeb & Loeb PTAB Trials Head In Calif.
International law firm Sterlington PLLC has added a partner who has guided clients in more than 140 proceedings before the U.S. Patent Trial and Appeal Board, strengthening its intellectual property practice with the former chair of Loeb & Loeb's PTAB trials practice, the firm announced Wednesday.
-
April 16, 2025
Texas Law Firm Hits Rival With Web Search Keywords Suit
Texas personal injury firm Thomas J. Henry Law has claimed in a lawsuit filed in Texas federal court that a Lone Star State competitor is unlawfully capitalizing on his reputation by misdirecting web searches through the purchase of certain search keywords.
-
April 16, 2025
X Corp. On The Hook For $105M In Video IP Row, Jury Finds
X Corp. will have to cough up $105 million after a Dallas jury found Wednesday that it infringed a startup company's video sharing technology, awarding significantly less than the $632 million that the patent owner VidStream LLC had sought.
-
April 16, 2025
NC Hospital Beats Weight Loss Clinic's Trademark Suit
A North Carolina federal judge tossed a Tar Heel State weight loss clinic's trademark infringement suit, calling the clinic's mark "relatively weak" and finding it has "very little similarity" to the purportedly infringing mark used by the hospital and healthcare provider it sued.
-
April 16, 2025
Jack Nicklaus Granted $1M In Damages After NIL Win
Jack Nicklaus was granted $1 million Wednesday by a New York state court judge for damages incurred as a result of a preliminary injunction that prevented the golf legend from signing new commercial deals during now-dismissed litigation over the use of his name, image and likeness.
-
April 15, 2025
Astellas Bladder Drug Patent Survives Following Bench Trial
A Delaware federal judge on Tuesday held that generic-drug makers Lupin and Zydus Pharmaceuticals haven't shown "by clear and convincing evidence" that an Astellas Pharma patent covering the bladder medication Myrbetriq is invalid.
-
April 15, 2025
Biogen, Genentech Head To June Trial Over MS Drug Royalties
A California federal judge on Tuesday denied Biogen's bid for summary judgment in a high-stakes contract fight with Roche Holding AG subsidiary Genentech over patent royalties on multiple sclerosis drug sales, saying during a hearing that there's a material dispute over the contract's language and the case will be tried in June.
-
April 15, 2025
X Corp. Should Pay $632M For Stealing Video IP, Jury Hears
X Corp. systematically copied a startup's video sharing technology while stringing it along with promises of a partnership, VidStream LLC told a Dallas jury during closing arguments Tuesday in a $632 million intellectual property suit that has spanned nearly a decade.
-
April 15, 2025
Westlaw Rival Urges 3rd Circ. Intervention In AI Fair Use Case
Tech startup ROSS Intelligence has urged the Third Circuit to allow a quick appeal focusing on two key questions from a lower court decision concluding it infringed copyrighted material from Thomson Reuters' Westlaw platform to create an artificial intelligence-backed competing legal research tool.
-
April 15, 2025
Meta Used Pirated Data To Evaluate Licensing, Authors Say
A group of bestselling authors accusing Meta Platforms of copyright infringement allege the tech company downloaded databases with millions of pirated books not just to train its large language models, called Llama, but also to see whether it could develop them without licensing content, according to a newly unredacted summary judgment motion.
-
April 15, 2025
AI Artist Hires Atty Challenging Human-Only Copyright Rule
A Colorado artist suing the U.S. Copyright Office over its refusal to register a work created on an artificial intelligence platform has a new attorney — the same lawyer who is representing a computer scientist challenging the government agency's position that only human authors qualify for copyright protection.
-
April 15, 2025
Fed. Circ. Won't Rethink Prior Art Decision In Samsung Row
The Federal Circuit shot down tech developer Lynk Labs Inc.'s bid for the full appellate court to review when a patent application counts as prior art, cementing a win for patent challenger Samsung in the case.
-
April 15, 2025
3 USPTO Updates You Should Know About
Probationary patent examiners and trademark examining attorneys within 50 miles of the U.S. Patent and Trademark Office's Virginia offices will have to start working from those facilities, one of three recent changes at the agency. Here's what you need to know.
-
April 15, 2025
Microsoft, Okta Say Their Password Products Don't Infringe IP
Microsoft Corp. and information technology service management company Okta Inc. asked a California federal judge Monday for declarations that their password-generating products don't infringe a San Francisco company's patent covering a method for issuing time-based, one-time passwords.
-
April 15, 2025
Intel Says Withdrawal Of Fintiv Memo Doesn't Help VLSI Case
Intel says the U.S. Patent and Trademark Office's recent withdrawal of guidance on its discretionary-denial policy doesn't mean the Federal Circuit should revive a VLSI Technology chip patent, hitting back at VLSI's argument to the contrary.
-
April 15, 2025
Some GoPro Cameras Infringe Patent, Calif. Judge Rules
A California federal judge has ruled that several GoPro cameras infringe a patent revived by the Federal Circuit last year but said a jury needs to hear the issue of whether other products infringe.
-
April 15, 2025
Fed. Circ. Won't Revive Stryker Unit's Antiseptic Patents
The Patent Trial and Appeal Board properly invalidated claims in two Sage Products LLC patents for sterilizing antiseptics, the Federal Circuit affirmed Tuesday.
-
April 15, 2025
9th Circ. Backs $272M Verdict For Monster In Bang Ad Case
The Ninth Circuit on Tuesday affirmed a $272 million verdict for Monster Energy Co. in a false advertising case against defunct Vital Pharmaceuticals Inc. and its former CEO, rejecting a series of challenges to rulings that narrowed the evidence at trial.
-
April 15, 2025
Judge Again Denies Arbitration In Chicago Cubs License Spat
A Chicago federal court will not reconsider dismissing a lawsuit that accuses a rooftop owner of selling tickets to Chicago Cubs games and other events without a license, ruling it got it right the first time.
-
April 15, 2025
Hogan Lovells IP Pro Jumps To Venable In San Francisco
Venable LLP is expanding its intellectual property team, announcing Tuesday it is bringing in a Hogan Lovells IP litigator as a partner in its San Francisco office.
-
April 15, 2025
Holland & Knight Litigator Heads To Florida Boutique
Florida-based litigation and appellate boutique Lawson Huck Gonzalez PLLC has added a former Holland & Knight LLP partner to its Miami-area office, bringing on an attorney who has handled high-stakes litigation and appellate matters for clients in private practice.
-
April 15, 2025
Roster Limits Stay In Revisions To NCAA's NIL Settlement
In court-ordered revisions to their $2.78 billion antitrust class action settlement, the NCAA and the athlete class added greater protections for athletes entering college throughout the deal's 10-year span, but refused to budge on roster limits opposed by several objectors.
-
April 14, 2025
Backers Of Meta, Authors Clash Over Fair Use In AI Training
The conflict between bestselling authors and Meta Platforms Inc. over the use of their works for training artificial intelligence software has drawn numerous amicus briefs that underscore the stakes involved, with warnings of devastating consequences for the future of AI development or the rights of copyright owners depending on how the court rules.
-
April 14, 2025
Musk Supports Deleting IP Law, Attorneys Say Let's Not
Elon Musk's endorsement of a terse social media post from tech executive Jack Dorsey saying "delete all IP law" drew scorn from the intellectual property community and was followed by posts from U.S. Patent and Trademark Office acting Director Coke Morgan Stewart extolling the virtues of trademark, patent and copyright protections.
-
April 14, 2025
Fed. Circ. Hears Teva Challenge To J&J Schizophrenia Drug
A Federal Circuit panel on Monday grappled with how to determine whether a dosage patent on Johnson & Johnson's blockbuster schizophrenia drug Invega Sustenna is invalid as obvious, questioning attorneys for the company and generics maker Teva about the proper analysis.
Expert Analysis
-
Lights, Camera, Ethics? TV Lawyers Tend To Set Bad Example
Though fictional movies and television shows portraying lawyers are fun to watch, Hollywood’s inaccurate depictions of legal ethics can desensitize attorneys to ethics violations and lead real-life clients to believe that good lawyers take a scorched-earth approach, says Nancy Rapoport at the University of Nevada, Las Vegas.
-
Opinion
DOGE Should Address Inefficiency In The Patent Marketplace
Elon Musk's Department of Government Efficiency is well positioned to identify to Congress the necessary variability needed among individual patent rights, ensuring that the U.S. Patent and Trademark Office's current inefficiencies do not impede promising inventions from reaching the market, says John Powers at Powers IP.
-
Perspectives
Accountant-Owned Law Firms Could Blur Ethical Lines
KPMG’s recent application to open a legal practice in Arizona represents the first overture by an accounting firm to take advantage of the state’s relaxed law firm ownership rules, but enforcing and supervising the practice of law by nonattorneys could prove particularly challenging, says Seth Laver at Goldberg Segalla.
-
AI Will Soon Transform The E-Discovery Industrial Complex
Todd Itami at Covington discusses how generative artificial intelligence will reshape the current e-discovery paradigm, replacing the blunt instrument of data handling with a laser scalpel of fully integrated enterprise solutions — after first making e-discovery processes technically and legally harder.
-
IP, Licensing, M&A Trends To Watch In Life Sciences This Year
2025 promises to continue an exciting trajectory for the life sciences industry, with major trends ranging from global harmonization of intellectual property to cross-border licensing activity and an increase of nontraditional financial participants in the mergers and acquisition space, say attorneys at Morgan Lewis.
-
When Innovation Overwhelms The Rule Of Law
In an era where technology is rapidly evolving and artificial intelligence is seemingly everywhere, it’s worth asking if the law — both substantive precedent and procedural rules — can keep up with the light speed of innovation, says Reuben Guttman at Guttman Buschner.
-
Drug Pricing Policy Trends To Expect In 2025 And Beyond
Though 2025 may bring more of the same in the realm of drug pricing policy, business as usual entails a sustained, high level of legal and policy developments across at least six major areas, say attorneys at Ropes & Gray.
-
Imagine The Possibilities Of Openly Autistic Lawyering
Andi Mazingo at Lumen Law, who was diagnosed with autism about midway through her career, discusses how the legal profession can create inclusive workplaces that empower openly autistic lawyers and enhance innovation, and how neurodivergent attorneys can navigate the challenges and opportunities that come with disclosing one’s diagnosis.
-
Opinion
Courts Should Nix Conferencing Rule In 1 Discovery Scenario
Parties are generally required to meet and confer to resolve a discovery dispute before bringing a related motion, but courts should dispense with this conferencing requirement when a party fails to specify a time by which it will complete its production, says Tristan Ellis at Shanies Law.
-
Series
Documentary Filmmaking Makes Me A Better Lawyer
Becoming a documentary filmmaker has allowed me to merge my legal expertise with my passion for storytelling, and has helped me to hone negotiation, critical thinking and problem-solving skills that are important to both endeavors, says Robert Darwell at Sheppard Mullin.
-
Litigation Funding Disclosure Debate: Strategy Considerations
In the ongoing debate over whether courts should require disclosure of litigation funding, funders and plaintiffs tend to argue against such mandates, but voluntarily disclosing limited details about a funding arrangement can actually confer certain benefits to plaintiffs in some scenarios, say Andrew Stulce and Marc Cavan at Longford Capital.
-
FDA's Red No. 3 Ban Reshapes Food Safety Legal Landscape
The U.S. Food and Drug Administration's recent ban on Red No. 3 represents more than the end of a controversial dye — it signals a shift in regulatory priorities, consumer expectations, intellectual property strategy, compliance considerations and litigation risk, says Dino Haloulos at Foley Mansfield.
-
Series
Adventure Photography Makes Me A Better Lawyer
Photographing nature everywhere from Siberia to Cuba and Iceland to Rwanda provides me with a constant reminder to refresh, refocus and rethink the legal issues that my clients face, says Richard Birmingham at Davis Wright.
-
Fed. Circ. Inherency Ruling Refines Obviousness Framework
The Federal Circuit's December decision in Cytiva v. JSR has definitively eliminated the requirement of "reasonable expectation of success" analysis for inherent properties in obviousness determinations, while providing some key clarifications for patent practitioners, says Lawrence Kass at Steptoe.
-
5 Ways To Create Effective Mock Assignments For Associates
In order to effectively develop associates’ critical thinking skills, firms should design mock assignments that contain a few key ingredients, from messy fact patterns to actionable feedback, says Abdi Shayesteh at AltaClaro.